Both in Pharmaceuticals
Damora Therapeutics vs Omeros
Over the past year DMRA returned −23.1% and OMER returned −2.2%; their daily moves had a correlation of 0.16.
DMRA −23.1% OMER −2.2%Growth of $1, one year, split-adjusted
| Metric | DMRA | OMER |
|---|---|---|
| Price | $21.61 | $17.88 |
| Market cap | $1.33B | $1.29B |
| Today | −1.59% | +2.23% |
| 1 month | +4.6% | −7.1% |
| 6 months | — | +22.8% |
| Year to date | — | +4.1% |
| 1 year | — | +131.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 97.2% |
| Net margin | — | 46.4% |
| P/E (TTM) | — | 10.4× |
| Price / sales | — | 33.7× |
| Net cash | $540.5M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 75.8% |
| Short % of float | 11.2% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).